|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005864,
umls-concept:C0005865,
umls-concept:C0007226,
umls-concept:C0025939,
umls-concept:C0036043,
umls-concept:C0040833,
umls-concept:C0168273,
umls-concept:C0233820,
umls-concept:C0439608,
umls-concept:C0442043,
umls-concept:C0522523,
umls-concept:C1513822,
umls-concept:C1521798,
umls-concept:C1522318,
umls-concept:C1880171,
umls-concept:C1948041
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-5-25
|
|
pubmed:abstractText |
To evaluate the safety and efficacy of bivalirudin based therapy among patients undergoing percutaneous coronary intervention (PCI) for stable coronary artery disease in a large multicenter registry.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0896-4327
|
|
pubmed:author |
pubmed-author:Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2),
pubmed-author:CarterAndrew JAJ,
pubmed-author:ChetcutiStan JSJ,
pubmed-author:GurmHitinder SHS,
pubmed-author:KhanalSanjayaS,
pubmed-author:Kline-RogersEvaE,
pubmed-author:LalondeThomasT,
pubmed-author:MoscucciMauroM,
pubmed-author:O'DonnellMichaelM,
pubmed-author:O'NeillWilliamW,
pubmed-author:RibaArthurA,
pubmed-author:SafianRobertR,
pubmed-author:ShareDavidD,
pubmed-author:SmithDean EDE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
197-203
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17524111-Aged,
pubmed-meshheading:17524111-Aged, 80 and over,
pubmed-meshheading:17524111-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17524111-Anticoagulants,
pubmed-meshheading:17524111-Coronary Artery Disease,
pubmed-meshheading:17524111-Female,
pubmed-meshheading:17524111-Heparin,
pubmed-meshheading:17524111-Hirudins,
pubmed-meshheading:17524111-Humans,
pubmed-meshheading:17524111-Male,
pubmed-meshheading:17524111-Michigan,
pubmed-meshheading:17524111-Middle Aged,
pubmed-meshheading:17524111-Peptide Fragments,
pubmed-meshheading:17524111-Platelet Aggregation Inhibitors,
pubmed-meshheading:17524111-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:17524111-Recombinant Proteins,
pubmed-meshheading:17524111-Registries,
pubmed-meshheading:17524111-Risk Factors,
pubmed-meshheading:17524111-Surgical Procedures, Elective,
pubmed-meshheading:17524111-Time Factors,
pubmed-meshheading:17524111-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
|
|
pubmed:affiliation |
University of Michigan, Ann Arbor, MI 48103-0311, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
